AUTOLUS
Registro de marca em vigor (Madri)
Marca Nominativa depositada no INPI em
05/09/2023 por Autolus Limited,
processo nº 501754553, nas classes 05, 40, 42, 44.
Registro em vigor até 05/09/2033.
| Número do processo | 501754553 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 05/09/2023 |
|---|
| Data da concessão | 13/05/2025 |
|---|
| Vigência até | 05/09/2033 |
|---|
| Titular | Autolus Limited |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · GB |
Classes e especificação
Medical and veterinary preparations for therapeutic purposes; preparations for cell therapy; preparations for gene therapy; preparations for cancer therapies; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; vaccines.;
Custom manufacture of therapeutic drugs, namely cell therapies, cancer therapies and cancer vaccines.;
Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vaccines, including personalised cancer vaccines; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services.;
Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines.;